NCT06365762View on ClinicalTrials.gov

The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

January 1, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

April 30, 2007

Conditions
Age Related Cataracts
Interventions
DRUG

EDTA Ophthalmic Solution 2.6%

DRUG

EDTA Ophthalmic Solution 1.3%

DRUG

Saline Solution (Placebo)

Trial Locations (6)

21093

The Johns Hopkins Hospital & Health System, Wilmer Eye Institute, Lutherville

28210

Charlotte Eye, Ear, Nose, and Throat Associates, Charlotte

66210

Hunkeler Eye Institute, Overland Park

84132

University of Utah, John Moran Eye Center, Salt Lake City

94117

St Mary's Eye Specialists, Inc., San Francisco

02114

Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston

All Listed Sponsors
lead

Livionex Inc.

INDUSTRY

NCT06365762 - The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract | Biotech Hunter | Biotech Hunter